chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Dehydration, Headache, Pyrexia
Clinical narrative: Lack of energy; Dehydrate; Fever; Body ache; Headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Lack of energy), DEHYDRATION (Dehydrate), PYREXIA (Fever), ARTHRALGIA (Body ache) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Lack of energy), DEHYDRATION (Dehydrate), PYREXIA (Fever), ARTHRALGIA (Body ache) and HEADACHE (Headache). At the time of the report, ASTHENIA (Lack of energy), DEHYDRATION (Dehydrate), PYREXIA (Fever), ARTHRALGIA (Body ache) and HEADACHE (Headache) outcome was unknown.            No concomitant medications were reported No treatment information was provided
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia
Clinical narrative: fatigue; Minor Muscle pain (After Second Shot); joint pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Minor Muscle pain (After Second Shot)), ARTHRALGIA (joint pain) and FATIGUE (fatigue) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced MYALGIA (Minor Muscle pain (After Second Shot)) and ARTHRALGIA (joint pain). On 26-Apr-2021, the patient experienced FATIGUE (fatigue). On 28-Feb-2021, MYALGIA (Minor Muscle pain (After Second Shot)) and ARTHRALGIA (joint pain) had resolved. At the time of the report, FATIGUE (fatigue) had not resolved.         This case was linked to MOD-2021-025176 (Patient Link).
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Face Swelling; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Face Swelling) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No past medical history were reported.     On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced SWELLING FACE (Face Swelling). At the time of the report, SWELLING FACE (Face Swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were reported.  No treatment medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow up received on 27-MAY-2021 including form patient decline to give Email address. Patient stated that events resolved
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site rash
Clinical narrative: hives; rashes at injection site; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives) and VACCINATION SITE RASH (rashes at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 26-Apr-2021, the patient experienced VACCINATION SITE RASH (rashes at injection site). On an unknown date, the patient experienced URTICARIA (hives). At the time of the report, URTICARIA (hives) and VACCINATION SITE RASH (rashes at injection site) outcome was unknown. Not Provided          Concomitant medications were not provided.  Treatment information was not provided.   This case was linked to MOD21-081932 (E2B Linked Report). This case was linked to MOD-2021-090626 (Patient Link).; Sender's Comments:  MOD21-081932:
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhoea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (she started having diarrhea after she eats food/has continued even after she received her 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included NIFEDIPINE (PROCARDIA [NIFEDIPINE]) and ANASTROZOLE for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (she started having diarrhea after she eats food/has continued even after she received her 2nd dose). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-090566 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: Redness over her neck, jaw, and face; Itching over her neck, jaw, and face; Hives over her neck, jaw, and face; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness over her neck, jaw, and face), PRURITUS (Itching over her neck, jaw, and face) and URTICARIA (Hives over her neck, jaw, and face) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced ERYTHEMA (Redness over her neck, jaw, and face), PRURITUS (Itching over her neck, jaw, and face) and URTICARIA (Hives over her neck, jaw, and face). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Redness over her neck, jaw, and face), PRURITUS (Itching over her neck, jaw, and face) and URTICARIA (Hives over her neck, jaw, and face) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Follow-up information received on 02-Aug-2021 contains no new information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: inappropriate schedule of vaccine administered; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: blatter infection or kidney infection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URINARY TRACT INFECTION (blatter infection or kidney infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced URINARY TRACT INFECTION (blatter infection or kidney infection). At the time of the report, URINARY TRACT INFECTION (blatter infection or kidney infection) had not resolved.            It was reported that the patient went to the doctor and got tested two times with negative results. She hadn't recovered when she got the second dose. The patient reported that her symptoms got worse two weeks after the second dose. It was reported that she is scheduled to visit a urologist per her doctor's request. No treatment medications were reported.  Correction done Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Immunisation reaction, Joint swelling, Peripheral swelling
Clinical narrative: reaction to vaccine; swelling in joints; toes, ankles and calves were swollen, knees were also swollen; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Apr-2021 and was forwarded to Moderna on 26-Apr-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of JOINT SWELLING (swelling in joints), PERIPHERAL SWELLING (toes, ankles and calves were swollen, knees were also swollen) and IMMUNISATION REACTION (reaction to vaccine) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced JOINT SWELLING (swelling in joints) and PERIPHERAL SWELLING (toes, ankles and calves were swollen, knees were also swollen). On 26-Apr-2021, the patient experienced IMMUNISATION REACTION (reaction to vaccine). At the time of the report, JOINT SWELLING (swelling in joints), PERIPHERAL SWELLING (toes, ankles and calves were swollen, knees were also swollen) and IMMUNISATION REACTION (reaction to vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported . No treatment medication was reported .
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Malaise, Myalgia, Pain
Clinical narrative: feel like I had the flu; muscle aches; Joint aches; achy all over body; felt like I was 90 years old; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feel like I had the flu), MYALGIA, ARTHRALGIA, PAIN, and FEELING ABNORMAL in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY. On 10-Apr-2021, the patient experienced MALAISE, MYALGIA, ARTHRALGIA, PAIN, and FEELING ABNORMAL. On 23-Apr-2021, MALAISE, MYALGIA, ARTHRALGIA, PAIN, FEELING ABNORMAL, and PAIN IN EXTREMITY had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC-MOD-2021-090547, US-MODERNATX, INC-MOD-2021-090554. This case was linked to MOD-2021-090569; Sender's Comments:  US-MODERNATX, INC-MOD-2021-090547: dose 1 case US-MODERNATX, INC-MOD-2021-090554: dose 2 case
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: feel like I had the flu; muscle aches; Joint aches; achy all over body; felt like I was 90 years old; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feel like I had the flu), MYALGIA, ARTHRALGIA, PAIN, and FEELING ABNORMAL in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY. On 10-Apr-2021, the patient experienced MALAISE, MYALGIA, ARTHRALGIA, PAIN, and FEELING ABNORMAL. On 23-Apr-2021, MALAISE, MYALGIA, ARTHRALGIA, PAIN, FEELING ABNORMAL, and PAIN IN EXTREMITY had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC-MOD-2021-090547, US-MODERNATX, INC-MOD-2021-090554. This case was linked to MOD-2021-090569; Sender's Comments:  US-MODERNATX, INC-MOD-2021-090547: dose 1 case US-MODERNATX, INC-MOD-2021-090554: dose 2 case
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: soreness in left arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (soreness in left arm) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness in left arm). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 17-Apr-2021, PAIN IN EXTREMITY (soreness in left arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Physical examination, Renal impairment
Clinical narrative: Terrible aches and pains all over body; feeling tired; headache; Slightly out of normal kidney function; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RENAL IMPAIRMENT (Slightly out of normal kidney function), PAIN (Terrible aches and pains all over body), FATIGUE (feeling tired) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Atrial fibrillation (ten year history), Congestive heart failure, Chronic rhinitis (excl allergic) (for years) and Cardiac ablation in June 2020.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced RENAL IMPAIRMENT (Slightly out of normal kidney function). On 27-Feb-2021, the patient experienced PAIN (Terrible aches and pains all over body), FATIGUE (feeling tired) and HEADACHE (headache). On 25-Mar-2021, RENAL IMPAIRMENT (Slightly out of normal kidney function) and PAIN (Terrible aches and pains all over body) had resolved. At the time of the report, FATIGUE (feeling tired) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Physical examination: showed i had a slightly out of (abnormal) showed I had a slightly out of normal range kidney function.         The patient took extra strength Tylenol three times through the day just so not to have such terrible aches and pains all over my body.  Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   This case was linked to MOD-2021-018720 (Patient Link).; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, COVID-19, Dizziness, Fatigue
Clinical narrative: covid; felt bad; was not feeling well; feeling weak; pain everywhere; sometimes he feel cold; somtimes he sweats; When he wakes up in the morning he feel good but later on he feel weak and drowsy; pain in hip and can barely walk; Dizzy; fever; feels so tired; headache; pain in hip; pain in the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad), MALAISE (was not feeling well), ASTHENIA (feeling weak), PAIN (pain everywhere) and FEELING COLD (sometimes he feel cold) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced FEELING ABNORMAL (felt bad), MALAISE (was not feeling well), ASTHENIA (feeling weak), PAIN (pain everywhere), FEELING COLD (sometimes he feel cold), HYPERHIDROSIS (somtimes he sweats), SOMNOLENCE (When he wakes up in the morning he feel good but later on he feel weak and drowsy), GAIT DISTURBANCE (pain in hip and can barely walk), DIZZINESS (Dizzy), PYREXIA (fever), FATIGUE (feels so tired), HEADACHE (headache), ARTHRALGIA (pain in hip) and ARTHRALGIA (pain in the shoulder). On 28-May-2021, the patient experienced COVID-19 (covid). The patient was treated with ACETAMINOPHEN at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (felt bad), MALAISE (was not feeling well), ASTHENIA (feeling weak), PAIN (pain everywhere), FEELING COLD (sometimes he feel cold), HYPERHIDROSIS (somtimes he sweats), SOMNOLENCE (When he wakes up in the morning he feel good but later on he feel weak and drowsy), GAIT DISTURBANCE (pain in hip and can barely walk), DIZZINESS (Dizzy), PYREXIA (fever), FATIGUE (feels so tired), HEADACHE (headache), ARTHRALGIA (pain in hip), ARTHRALGIA (pain in the shoulder) and COVID-19 (covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up received on 28 May 2021 and new event ( COVID-19 ) was added. On 24-Jul-2021: Follow up information received on 24 Jul 2021 included no new information
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Feeling cold, Gait disturbance, Headache, Hyperhidrosis
Clinical narrative: covid; felt bad; was not feeling well; feeling weak; pain everywhere; sometimes he feel cold; somtimes he sweats; When he wakes up in the morning he feel good but later on he feel weak and drowsy; pain in hip and can barely walk; Dizzy; fever; feels so tired; headache; pain in hip; pain in the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad), MALAISE (was not feeling well), ASTHENIA (feeling weak), PAIN (pain everywhere) and FEELING COLD (sometimes he feel cold) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced FEELING ABNORMAL (felt bad), MALAISE (was not feeling well), ASTHENIA (feeling weak), PAIN (pain everywhere), FEELING COLD (sometimes he feel cold), HYPERHIDROSIS (somtimes he sweats), SOMNOLENCE (When he wakes up in the morning he feel good but later on he feel weak and drowsy), GAIT DISTURBANCE (pain in hip and can barely walk), DIZZINESS (Dizzy), PYREXIA (fever), FATIGUE (feels so tired), HEADACHE (headache), ARTHRALGIA (pain in hip) and ARTHRALGIA (pain in the shoulder). On 28-May-2021, the patient experienced COVID-19 (covid). The patient was treated with ACETAMINOPHEN at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (felt bad), MALAISE (was not feeling well), ASTHENIA (feeling weak), PAIN (pain everywhere), FEELING COLD (sometimes he feel cold), HYPERHIDROSIS (somtimes he sweats), SOMNOLENCE (When he wakes up in the morning he feel good but later on he feel weak and drowsy), GAIT DISTURBANCE (pain in hip and can barely walk), DIZZINESS (Dizzy), PYREXIA (fever), FATIGUE (feels so tired), HEADACHE (headache), ARTHRALGIA (pain in hip), ARTHRALGIA (pain in the shoulder) and COVID-19 (covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up received on 28 May 2021 and new event ( COVID-19 ) was added. On 24-Jul-2021: Follow up information received on 24 Jul 2021 included no new information
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Pain, Pyrexia, SARS-CoV-2 test, Somnolence
Clinical narrative: covid; felt bad; was not feeling well; feeling weak; pain everywhere; sometimes he feel cold; somtimes he sweats; When he wakes up in the morning he feel good but later on he feel weak and drowsy; pain in hip and can barely walk; Dizzy; fever; feels so tired; headache; pain in hip; pain in the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad), MALAISE (was not feeling well), ASTHENIA (feeling weak), PAIN (pain everywhere) and FEELING COLD (sometimes he feel cold) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced FEELING ABNORMAL (felt bad), MALAISE (was not feeling well), ASTHENIA (feeling weak), PAIN (pain everywhere), FEELING COLD (sometimes he feel cold), HYPERHIDROSIS (somtimes he sweats), SOMNOLENCE (When he wakes up in the morning he feel good but later on he feel weak and drowsy), GAIT DISTURBANCE (pain in hip and can barely walk), DIZZINESS (Dizzy), PYREXIA (fever), FATIGUE (feels so tired), HEADACHE (headache), ARTHRALGIA (pain in hip) and ARTHRALGIA (pain in the shoulder). On 28-May-2021, the patient experienced COVID-19 (covid). The patient was treated with ACETAMINOPHEN at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (felt bad), MALAISE (was not feeling well), ASTHENIA (feeling weak), PAIN (pain everywhere), FEELING COLD (sometimes he feel cold), HYPERHIDROSIS (somtimes he sweats), SOMNOLENCE (When he wakes up in the morning he feel good but later on he feel weak and drowsy), GAIT DISTURBANCE (pain in hip and can barely walk), DIZZINESS (Dizzy), PYREXIA (fever), FATIGUE (feels so tired), HEADACHE (headache), ARTHRALGIA (pain in hip), ARTHRALGIA (pain in the shoulder) and COVID-19 (covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up received on 28 May 2021 and new event ( COVID-19 ) was added. On 24-Jul-2021: Follow up information received on 24 Jul 2021 included no new information
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: Received 0.3 mL instead of 0.5 mL; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (Received 0.3 mL instead of 0.5 mL) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 016B21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Drug allergy (Zoloft). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 25-Jun-2020 to an unknown date for Postpartum state.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .3 ml. On 23-Apr-2021, the patient experienced ACCIDENTAL UNDERDOSE (Received 0.3 mL instead of 0.5 mL). On 23-Apr-2021, ACCIDENTAL UNDERDOSE (Received 0.3 mL instead of 0.5 mL) had resolved. Not Provided          No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.   This case was linked to MOD-2021-090607 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up information received on 04-Jun-2021 included patient demographics, medical history, dose 1 and 2 details and concomitant medications added.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Taste disorder
Clinical narrative: more of metallic taste; something different taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (more of metallic taste) and TASTE DISORDER (something different taste in mouth) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021 at 10:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced DYSGEUSIA (more of metallic taste) and TASTE DISORDER (something different taste in mouth). At the time of the report, DYSGEUSIA (more of metallic taste) and TASTE DISORDER (something different taste in mouth) was resolving.            No relevant concomitant medications were reported. Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Outcome of the events was updated from Unknown to recovering
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: only got the first dose by day 36; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (only got the first dose by day 36) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (only got the first dose by day 36). On 01-Mar-2021, PRODUCT DOSE OMISSION ISSUE (only got the first dose by day 36) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Antibody test negative, Fatigue, Pain, Pyrexia
Clinical narrative: achiness; antibody test showed negative; tiredness; a little bit of fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achiness), ANTIBODY TEST NEGATIVE (antibody test showed negative), FATIGUE (tiredness) and PYREXIA (a little bit of fever) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (achiness), ANTIBODY TEST NEGATIVE (antibody test showed negative), FATIGUE (tiredness) and PYREXIA (a little bit of fever). At the time of the report, PAIN (achiness), ANTIBODY TEST NEGATIVE (antibody test showed negative), FATIGUE (tiredness) and PYREXIA (a little bit of fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-090605 (Patient Link).
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Feeling abnormal
Clinical narrative: cough; felt bad; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Apr-2021 and was forwarded to Moderna on 26-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad) and COUGH (cough) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032BZLA) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced FEELING ABNORMAL (felt bad). On an unknown date, the patient experienced COUGH (cough). At the time of the report, FEELING ABNORMAL (felt bad) and COUGH (cough) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment with Tylenol was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-090146 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090146:Case for wife
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site rash
Clinical narrative: Fever; big rash on her left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (big rash on her left arm) and PYREXIA (Fever) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced VACCINATION SITE RASH (big rash on her left arm). On 21-Apr-2021, the patient experienced PYREXIA (Fever). On 06-Apr-2021, VACCINATION SITE RASH (big rash on her left arm) had resolved. On 22-Apr-2021, PYREXIA (Fever) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details not provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Nasal congestion, Rhinorrhoea
Clinical narrative: developed runny nose today; feel congested; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (developed runny nose today) and NASAL CONGESTION (feel congested) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced RHINORRHOEA (developed runny nose today) and NASAL CONGESTION (feel congested). At the time of the report, RHINORRHOEA (developed runny nose today) and NASAL CONGESTION (feel congested) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Apr-2021, COVID-19: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient stated that he got the first vaccine on 30-MAR-2021 scheduled for second dose on 27-APR-2021. He teste positive for Covid on 26-Apr-2021. He said that his daughter and son in law tested positive last week and He had exposure through their 6 month old child. he developed runny nose on that day and felt congested but nothing else. no Treatment medications were reported. No Concomitant medications were reported.  Treatment information provided by reporter Benadryl
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Fatigue, Muscle spasms, Ocular hyperaemia
Clinical narrative: abdominal pain; 104'F fever; diarrhea; bloodshot on eyes (patient usually wears contacts, but eyes are not clear); legs tight/crampy; tired; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (abdominal pain), PYREXIA (104'F fever), DIARRHOEA (diarrhea), OCULAR HYPERAEMIA (bloodshot on eyes (patient usually wears contacts, but eyes are not clear)) and MUSCLE SPASMS (legs tight/crampy) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced ABDOMINAL PAIN (abdominal pain), PYREXIA (104'F fever), DIARRHOEA (diarrhea), OCULAR HYPERAEMIA (bloodshot on eyes (patient usually wears contacts, but eyes are not clear)), MUSCLE SPASMS (legs tight/crampy) and FATIGUE (tired). At the time of the report, ABDOMINAL PAIN (abdominal pain), PYREXIA (104'F fever), DIARRHOEA (diarrhea), OCULAR HYPERAEMIA (bloodshot on eyes (patient usually wears contacts, but eyes are not clear)), MUSCLE SPASMS (legs tight/crampy) and FATIGUE (tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product was reported by the reporter  Treatment patients Wife was not sure but maybe the patient took Ibuprofen to treat symptoms.   This case was linked to US-MODERNATX, INC.-MOD-2021-090599 (E2B Linked Report).
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: abdominal pain; 104'F fever; diarrhea; bloodshot on eyes (patient usually wears contacts, but eyes are not clear); legs tight/crampy; tired; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (abdominal pain), PYREXIA (104'F fever), DIARRHOEA (diarrhea), OCULAR HYPERAEMIA (bloodshot on eyes (patient usually wears contacts, but eyes are not clear)) and MUSCLE SPASMS (legs tight/crampy) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced ABDOMINAL PAIN (abdominal pain), PYREXIA (104'F fever), DIARRHOEA (diarrhea), OCULAR HYPERAEMIA (bloodshot on eyes (patient usually wears contacts, but eyes are not clear)), MUSCLE SPASMS (legs tight/crampy) and FATIGUE (tired). At the time of the report, ABDOMINAL PAIN (abdominal pain), PYREXIA (104'F fever), DIARRHOEA (diarrhea), OCULAR HYPERAEMIA (bloodshot on eyes (patient usually wears contacts, but eyes are not clear)), MUSCLE SPASMS (legs tight/crampy) and FATIGUE (tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product was reported by the reporter  Treatment patients Wife was not sure but maybe the patient took Ibuprofen to treat symptoms.   This case was linked to US-MODERNATX, INC.-MOD-2021-090599 (E2B Linked Report).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Electrocardiogram, Hypoaesthesia, Paraesthesia, Vertigo
Clinical narrative: Vertigo; numbness in chest; tingling in arms; dizzy; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), HYPOAESTHESIA (numbness in chest), PARAESTHESIA (tingling in arms) and DIZZINESS (dizzy) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     Concurrent medical conditions included Vertigo.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced DIZZINESS (dizzy). On 14-Apr-2021, the patient experienced VERTIGO (Vertigo), HYPOAESTHESIA (numbness in chest) and PARAESTHESIA (tingling in arms). On 01-Apr-2021, DIZZINESS (dizzy) had resolved. At the time of the report, VERTIGO (Vertigo), HYPOAESTHESIA (numbness in chest) and PARAESTHESIA (tingling in arms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: abnormal (abnormal) Vertigo diagnosed. On an unknown date, X-ray: abnormal (abnormal) Vertigo diagnosed.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient had a lot of health issues and a breathing condition. No concomitant medication provided.  No treatment medication were reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: Vertigo; numbness in chest; tingling in arms; dizzy; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), HYPOAESTHESIA (numbness in chest), PARAESTHESIA (tingling in arms) and DIZZINESS (dizzy) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     Concurrent medical conditions included Vertigo.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced DIZZINESS (dizzy). On 14-Apr-2021, the patient experienced VERTIGO (Vertigo), HYPOAESTHESIA (numbness in chest) and PARAESTHESIA (tingling in arms). On 01-Apr-2021, DIZZINESS (dizzy) had resolved. At the time of the report, VERTIGO (Vertigo), HYPOAESTHESIA (numbness in chest) and PARAESTHESIA (tingling in arms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: abnormal (abnormal) Vertigo diagnosed. On an unknown date, X-ray: abnormal (abnormal) Vertigo diagnosed.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient had a lot of health issues and a breathing condition. No concomitant medication provided.  No treatment medication were reported.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose, Vaccination site pain
Clinical narrative: Vaccine underdose; soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (Vaccine underdose) and VACCINATION SITE PAIN (soreness at injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 016B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PAIN (soreness at injection site). On an unknown date, the patient experienced UNDERDOSE (Vaccine underdose). At the time of the report, UNDERDOSE (Vaccine underdose) had resolved and VACCINATION SITE PAIN (soreness at injection site) outcome was unknown.            Concomitant products were not provided/unknown. Treatment medication were not reported/unknown. Action taken with mRNA-1273 in response to the drug was not applicable.   This case was linked to MOD-2021-090591 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: instead of Moderna 2nd dose patient received Pfizer vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTRATION ERROR (instead of Moderna 2nd dose patient received Pfizer vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (instead of Moderna 2nd dose patient received Pfizer vaccine). At the time of the report, PRODUCT ADMINISTRATION ERROR (instead of Moderna 2nd dose patient received Pfizer vaccine) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Big red itchy welt at injection site; Big red itchy welt at injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PRURITUS (Big red itchy welt at injection site) and VACCINATION SITE ERYTHEMA (Big red itchy welt at injection site) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), MULTIVITAMINS [VITAMINS NOS], ZINC, CALCIUM CITRATE, COLECALCIFEROL (CITRACAL PLUS D) and ELDERBERRY [SAMBUCUS NIGRA] for an unknown indication.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 24-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Big red itchy welt at injection site) and VACCINATION SITE ERYTHEMA (Big red itchy welt at injection site). On 17-Apr-2021, PAIN IN EXTREMITY (Sore arm) had resolved. On 24-Apr-2021, VACCINATION SITE PRURITUS (Big red itchy welt at injection site) and VACCINATION SITE ERYTHEMA (Big red itchy welt at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment medication was reported.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided          The action taken with mRNA-1273(Moderna COVID-19 Vaccine) was not applicable No concomitant medications were reported No treatment drugs were reported
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: accidentally administered 1ml of the vaccine; This spontaneous case was reported by a physician and describes the occurrence of INCORRECT DOSE ADMINISTERED (accidentally administered 1ml of the vaccine) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced INCORRECT DOSE ADMINISTERED (accidentally administered 1ml of the vaccine). At the time of the report, INCORRECT DOSE ADMINISTERED (accidentally administered 1ml of the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant drugs included no treatment drugs included   This case was linked to MOD21-082152, US-MODERNATX, INC.-MOD-2021-090288, US-MODERNATX, INC.-MOD-2021-090426, US-MODERNATX, INC.-MOD-2021-090625 (E2B Linked Report).; Sender's Comments:  MOD21-082152: US-MODERNATX, INC.-MOD-2021-090288: US-MODERNATX, INC.-MOD-2021-090426: US-MODERNATX, INC.-MOD-2021-090625: